Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HALO - Halozyme: A Stalwart With More Upside

HALO - Halozyme: A Stalwart With More Upside

Halozyme Therapeutics Inc.
  • Halozyme is currently in the stalwart phase with approximately less than 50% more upsides.
  • The company shifted focus to employing a low-risk business model. They're out-licensing their Enhanze technology to other large pharmas.
  • With an increasing number of blockbusters being reformulated via Enhanze, Halozyme is enjoying aggressive revenues and earnings growth.

For further details see:

Halozyme: A Stalwart With More Upside
Stock Information
Company Name: Halozyme Therapeutics Inc.
Stock Symbol: HALO
Market: NASDAQ
Website: halozyme.com
Menu
HALO HALO Quote HALO Short HALO News HALO Articles HALO Message Board
Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...